BioShares Biotechnology Price Prediction

BioShares Biotechnology Products -- USA Etf  

USD 41.3  0.59  1.44%

Macroaxis is not in business of monitoring BioShares Biotechnology headlines and social sentiment data; there are plenty of companies out there that do it quite successfully. However, we do analyze noise-free headlines and recent hype associated with BioShares Biotechnology Products brand which may create opportunities for some arbitrage if properly timed. With BioShares Biotechnology hype-based prediction module you can estimate the value of BioShares Biotechnology Products from the prospective of BioShares Biotechnology response to recently generated media hype and the effects of current headlines on its competitors. The module also provides analysis of price elasticity to changes in media outlook on BioShares Biotechnology over a specific investment horizon. Check also BioShares Biotechnology Basic Forecasting Models to cross-verify your projections.
 Time Horizon     30 Days    Login   to change

BioShares Biotechnology Estimiated After-Hype Price Volatility

 Next price density 
 
Expected price to next headline
January 19, 2018
41.3
Current Value
Downside upside
41.31
After-hype Price
Target Price Odds
 Above  Below  
44.61
Upside
Upside upside
BioShares Biotechnology is not too risky asset. Analysis and calculation of next after-hype price of BioShares Biotechnology is based on 1 month time horizon.

BioShares Biotechnology Hype Analysis

Daily Expected returnPeriod VolatilityHype elasticityRelated hype elasticityAverage news densityRelated news densityNext Expected Hype
 0.19% 1.1% 0.01%  0.04% 1 Events / Month1 Events / MonthVery soon
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
41.341.310.02%
3,374% 

BioShares Biotechnology Hype Timeline

On 19 of January BioShares Biotechnology Products is traded for 41.3. This company has historical hype elasticity of 0.01 and average elasticity to hype of competition of 0.04. BioShares Biotechnology Products is estimated to increase in value after the next headline with price going to jump to 41.31. The average volatility of media hype impact on the company stock price is about 3374.23%. The price escalation on the next news is estimated to be 0.02% where as daily expected return is currently at 0.19%. The volatility of related hype on BioShares Biotechnology is about 511.63% with expected price after next announcement by competition of 41.34. Considering 30-days investment horizon, the next estimated press release will be very soon.
Check also BioShares Biotechnology Basic Forecasting Models to cross-verify your projections.

BioShares Biotechnology Related Hype Analysis

Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Expected
Short fall
Potential
Upside
Value
At Risk
Maximum
Drawdown
Health Care Select Sector SPDR ETF 0.01 1 per month 0.00 (0.1) (0.52)  1.12 (0.36)  1.49 
iShares Nasdaq Biotechnology(0.12) 1 per month 0.44 (0.0893) (0.72)  1.88 (1.23)  3.74 
Vanguard Health Care ETF 0.08 1 per month 0.00 (0.1) (0.52)  1.24 (0.48)  1.72 
SPDR SP Biotech ETF 0.2 1 per month 1.35  0.0322 (1.23)  2.56 (1.99)  5.86 
iShares US Healthcare 0.28 1 per month 0.00 (0.14) (0.55)  1.13 (0.48)  1.62 
iShares Global Healthcare 0.84 1 per month 0.00 (0.23) (0.5)  1.04 (0.45)  1.48